The APCR (Activated Protein C) test is used to diagnose Factor V Leiden mutation and assess the risk of thrombophilia. It helps evaluate patients with recurrent or unexplained blood clots and can guide treatment decisions, particularly regarding anticoagulant therapy to prevent future clot formation

